The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis
Open accessAbstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is a common condition affecting ∼8% of women. The objective of the present study was to quantify separately the risk of endometrial cancer, ovarian cancer and breast cancer in women with PCOS compared with non-PCOS controls, and quantify separately the risk to women of all ages as well as the risk to premenopausal women. METHODS: We conducted a systematic review and meta-analysis of observational studies. Studies were eligible for inclusion if they compared women with PCOS to non-PCOS groups for fatal or non-fatal gynaecological cancers. Studies listed in MEDLINE and EMBASE published up to 7 October 2013 in any language were identified, and relevant papers were also searched by hand. Relevant data (for example, study design, source of control data, diagnostic criteria) were extracted and tabulated. RESULTS: From 698 references, 11 studies (5 of endometrial cancer and 3 each of ovarian and breast cancer) met the inclusion criteria for the meta-analysis (919 women with PCOS and 72054 non-PCOS controls). Using the Mantel-Haenszel method, with fixed or random effects model as appropriate, women with PCOS were at a significantly increased risk of endometrial cancer (odds ratio (OR), 2.79; 95% confidence interval (CI), 1.31-5.95, P < 0.008), but the risk of ovarian and breast cancers was not significantly increased (OR, 1.41; 95% CI, 0.93-2.15, P < 0.11 and OR, 0.95; 95% CI, 0.64-1.39, P < 0.78, respectively). However when studies which included women aged over 54 years were excluded from the analysis, the risk for women with PCOS increased further for endometrial cancer (OR, 4.05; 95% CI, 2.42-6.76, P < 0.00001), became significantly increased for ovarian cancer (OR, 2.52; 95% CI, 1.08-5.89, P < 0.03), but remained non-significant for breast cancer (OR, 0.78; 95% CI, 0.46-1.32, P < 0.35). CONCLUSIONS: This is the first meta-analysis to examine gynaecological cancers in women with PCOS younger than 54 years of age compared with controls of similar age. Current data suggest that women of all ages with PCOS are at an increased risk of endometrial cancer but the risk of ovarian and breast cancer was not significantly increased overall. These results highlight the potential risk of gynaecological cancer morbidities associated with PCOS. However, the available evidence is far from robust and variation in diagnostic criteria for PCOS, associated risk factors (particularly obesity), and selection bias in the studies may have resulted in an exaggeration of the increased risk. Furthermore, women who have PCOS should also be made aware that any increased risk for endometrial cancer must be judged in the context of its relatively low incidence in the general population. A large well-controlled prospective study is required in order to gain a more accurate estimate of the risk of gynaecological cancers in women with PCOS. PROSPERO CRD REGISTRATION NUMBER: CRD42012003500.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529786 · Cited by 4,332 · cited 1×
“A Kappa of 0.41–0.60 is generally considered as demonstrating ‘moderate agreement’ and 0.61–0.80 is ‘substantial agreement’ (Landis and Koch, 1977); The NOS scores of J.A.B. and M.M.A. were in substantial agreement, as shown by the Cohen’s Kappa of 0.750 (P , 0.00002).”
ResultInfluentialThe Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
Polson, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 906
Wang, E.-Y., & Li, S.-Y. (1990) · Cited by 884
Key, T., & Pike, M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.44 · Cited by 547
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
Giovannucci, E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.836s · Cited by 531
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · cited 3×
“Inconsistent findings also exist regarding the prevalence of breast cancer in women with PCOS (Anderson et al., 1997; Pierpoint et al., 1998).”
BackgroundResultMetformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Broekmans, F., Knauff, E., Valkenburg, O., Laven, J., Eijkemans, M., & Fauser, B. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01008.x · Cited by 442
Polycystic ovary syndrome and endometrial carcinoma
Hardiman, P., Pillay, O. S., & Atiomo, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13409-5 · Cited by 414
Self-citationClayton, R. N., Ogden, V., Hodgkinson, J., Worswick, L., Rodin, D. A., Dyer, S., & Meade, T. W. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02296.x · Cited by 357
Adenocarcinoma of the endometrium in women 40 years of age or younger.
GALLUP, D. G., & Stock, R. J. (1984) · PubMed · Cited by 348
Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome
SCHILDKRAUT, J. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(96)00226-8 · Cited by 337
Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study
Wild, S., Pierpoint, T., Jacobs, H., & McKeigue, P. (2000) · Human Fertility · doi:10.1080/1464727002000198781 · Cited by 306
Pathophysiology and types of dyslipidemia in PCOS
Diamanti-Kandarakis, E., Papavassiliou, A. G., Kandarakis, S. A., & Chrousos, G. P. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.004 · Cited by 299
Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review
Chittenden, B., Fullerton, G., Maheshwari, A., & Bhattacharya, S. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60175-7 · Cited by 279
Chronic anovulation syndrome and associated neoplasia.
Coulam, C. B., Annegers, J. F., & Kranz, J. S. (1983) · PubMed · Cited by 253
Evaluating the association between endometrial cancer and polycystic ovary syndrome
Haoula, Z., Salman, M., & Atiomo, W. (2012) · Human Reproduction · doi:10.1093/humrep/des042 · Cited by 243
THE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME
Solomon, C. G. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70069-4 · Cited by 226
Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria
Shroff, R., Syrop, C. H., Davis, W., Van Voorhis, B. J., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.032 · Cited by 214
Jackson, R. L., & Dockerty, M. B. (1957) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)37277-5 · Cited by 200
The Australian Ovarian Cancer Study Group and The Australian National Endometrial Cancer Study Group, Fearnley, E. J., Marquart, L., Spurdle, A. B., Weinstein, P., & Webb, P. M. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9658-7 · Cited by 162
Use of metformin and the risk of ovarian cancer: A case–control analysis
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.038 · Cited by 159
Selected medical conditions and risk of breast cancer
Talamini, R., Franceschi, S., Favero, A., Negri, E., Parazzini, F., & Vecchia, C. L. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.289 · Cited by 143
The association between polycystic ovaries and endometrial cancer
Pillay, O., Fong, L. F. W. T., Crow, J. C., Benjamin, E. O., Mould, T., Atiomo, W., Menon, P., Leonard, A., & Hardiman, P. (2005) · Human Reproduction · doi:10.1093/humrep/dei420 · Cited by 136
Self-citationA systematic review of the impact of weight loss on cancer incidence and mortality
Birks, S., Peeters, A., Backholer, K., O'Brien, P., & Brown, W. A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01010.x · Cited by 121
Carcinoma of the corpus uteri in young women
Dockerty, M. B., Lovelady, S. B., & Foust, G. T. (1951) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(51)90298-0 · Cited by 120
Hormone-related factors and gynecological conditions in relation to endometrial cancer risk
Zucchetto, A., Serraino, D., Polesel, J., Negri, E., Paoli, A. D., Maso, L. D., Montella, M., Vecchia, C. L., Franceschi, S., & Talamini, R. (2009) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328329d830 · Cited by 118
Polycystic Ovaries and the Risk of Breast Cancer
Gammon, M. D., & Thompson, W. D. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116156 · Cited by 115
Epithelial ovarian cancer: testing the 'androgens hypothesis'
Olsen, C. M., Green, A. C., Nagle, C. M., Jordan, S. J., Whiteman, D. C., Bain, C., Webb, P. M., & on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0075 · Cited by 113
Endometrial carcinoma; ovarian dysfunction — a risk factor in young women
Dahlgren, E., Friberg, L.-G., Johansson, S., Lindström, B., Odén, A., Samsioe, G., & Janson, P. O. (1991) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(91)90092-y · Cited by 112
Polycystic ovary syndrome and gynecological cancers: Is there a link?
Gadducci, A., Gargini, A., Palla, E., FANUCCHI, A., & Genazzani, A. R. (2005) · Gynecological Endocrinology · doi:10.1080/09513590400021201 · Cited by 107
Anderson, K. E., Sellers, T. A., Chen, P., Rich, S. S., Hong, C.-P., & Folsom, A. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<494::aid-cncr10>3.0.co;2-z · Cited by 105
Carcinoma of the endometrium in young women.
Speert, H. (1949) · PubMed · Cited by 98
Metabolic disorders and breast cancer risk (United States)
Baron, J. A., Weiderpass, E., Newcomb, P. A., Stampfer, M. J., Titus-Ernstoff, L. T., Egan, K. M., & Greenberg, E. R. (2001) · Cancer Causes & Control · doi:10.1023/a:1013796112348 · Cited by 93
Escobedo, L., Lee, N. C., Peterson, H., & Wingo, P. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90508-3 · Cited by 81
Hormone replacement therapy and cancer
Genazzani, A. R., Gadducci, A., & Gambacciani, M. (2001) · Climacteric · doi:10.1080/cmt.4.3.181.193 · Cited by 78
A case-control study of uterine endometrial cancer of pre- and post-menopausal women.
Niwa, K., Imai, A., Hashimoto, M., Yokoyama, Y., Mori, H., Matsuda, Y., & Tamaya, T. (2000) · Oncology Reports · doi:10.3892/or.7.1.89 · Cited by 66
Polycystic Ovaries A Common Finding in Normal Women
POLSON, D. W., Wadsworth, J., Adams, J. M., & Franks, S. (1988) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198810000-00017 · Cited by 62
Endometrial adenocarcinoma and the Stein-Leventhal syndrome.
Jafari, K., Javaheri, G., & Ruiz, G. (1978) · PubMed · Cited by 60
Controversial issues in climacteric medicine II
Genazzani, A. R., Gadducci, A., & Gambacciani, M. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00282-1 · Cited by 52
Lunde, O., & Tanbo, T. G. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701705189 · Cited by 44
Women younger than 50 years with endometrial cancer.
Iatrakis, G. M., Zervoudis, S., Saviolakis, A., Τρούλος, Μ., Antoniou, E., Sarantaki, A., Lykeridou, A., & Kourounis, G. (2006) · PubMed · Cited by 36
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
Ovalle, F. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79600-1 · Cited by 35
Mclaughlin, C., & Parkhouse, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90524-8 · Cited by 35
Hormone replacement therapy and cancer
Genazzani, A. R., Gadducci, A., & Gambacciani, M. (2001) · Climacteric · doi:10.1080/713605096 · Cited by 17
Endometrial abnormalities in infertile women.
Kurabayashi, T., Kase, H., Suzuki, M., Sugaya, S., Fujita, K., & Tanaka, K. (2003) · PubMed · Cited by 16
FREQUENCY OF POLY CYSTIC OVARY SYNDROME IN PATIENTS WITH PREMENOPAUSAL BREAST CANCER
Ghasemi, N., Mortazavizadeh, M. R., & Khorasani, A. (2010) · TSpace (University of Toronto) · Cited by 14
Cited by
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., González-Martín, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M. R., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv484 · Cited by 1,386
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
“Women with PCOS are at increased risk for metabolic syndrome, diabetes mellitus, and complications of pregnancy,(423) as well as endometrial cancer.(428) Nearly all women with PCOS have insulin resistance and this is aggravated by obesity and pregnancy.”
BackgroundESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., Gonzalez-Martin, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M. R., et al. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000609 · Cited by 767
Lu, K. H., & Broaddus, R. R. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1514010 · Cited by 663
Metadata
- Authors
- Barry, J. A., Azizia, M. M., & Hardiman, P. J.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-30
- Volume
- 20
- Issue
- 5
- Pages
- 748-758
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2148400658
- Cited by
- 597
- References
- 56
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.